Dwight Moxie - Jan 31, 2023 Form 4 Insider Report for Revance Therapeutics, Inc. (RVNC)

Role
SVP, GC & Secretary
Signature
/s/ Dwight Moxie
Stock symbol
RVNC
Transactions as of
Jan 31, 2023
Transactions value $
$0
Form type
4
Date filed
2/2/2023, 08:37 PM
Previous filing
Mar 9, 2023
Next filing
Mar 17, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVNC Employee Stock Option (Right to Buy) Award $0 +43.8K $0.00 43.8K Jan 31, 2023 Common Stock 43.8K $34.68 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the stock option shall vest in forty-eight (48) equal monthly installments beginning from January 31, 2023, subject to Mr. Moxie's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) on each vesting date.